In a previous video we discussed the relationship between risk management and the ISO14155. Today we’ll answer the following question:


“How is risk management integrated in the conduct of your clinical investigation?”




Whether it is related to monitoring or adverse events reporting, risk management activities should be performed continuously throughout the conduct of a clinical investigation.

The result of the risk assessment and the clinical development stage of the clinical investigation are used to create a risk-based monitoring plan and its supporting rationale. The extent and nature of this risk-based monitoring is determined by the sponsor, and can be performed in two ways: 

  1. through centralized monitoring, where the anonymized clinical data is assessed independently of location, 
  2. and through source data verification, where the clinical data is verified on site.

Do you want to make sure that you are properly managing all relevant data for risk-based monitoring in your clinical investigation? The In-depth ISO14155 training offers you all the information you need.

Share This Post

Other articles

Clinical Investigations

What has changed in the new ISO14155:2020 standard?

The ISO14155 provides an important guide on the use of Good Clinical Practice in clinical investigations. In the ISO14155 you’ll find the main requirements to: protect the well-being, safety and rights of human subjects in the clinical investigation; assure the scientific relevance of the investigation and the trustworthiness of its results; define what the sponsor


Harmonization EC approval process

In today’s video, I will briefly answer the following question:   “How is the approval process of Ethics Committees harmonized under the MDR?”      Transcript:   Ethics committees are responsible for evaluating a clinical investigation and determine whether ethical principles are being met. Requirements related to ethics committee composition and function are not specified in the

Scroll naar boven